Ann Oncol -- Table of Contents (May 2005, 16 [Supplement 3])

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 16, 2005 Supplement 3   [Index by Author]

       Introduction

       Abstracts

       Subject index

       Author index

3rd International Symposium in Targeted Anticancer Therapies, 3-5 March, 2005: Amsterdam, The Netherlands

Editors: G. Giaccone & M. W. Lobbezoo.

Find articles in this issue containing these words:
[Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Introduction:

: Committees
Ann Oncol 16: iii6; doi:10.1093/annonc/mdi622 [PDF]

: Welcome to TAT 2005!
Ann Oncol 16: iii8; doi:10.1093/annonc/mdi625 [PDF]

: Meeting sponsors
Ann Oncol 16: iii9; doi:10.1093/annonc/mdi624 [PDF]

: Meeting schedule
Ann Oncol 16: iii11-iii13; doi:10.1093/annonc/mdi600 [PDF]

Abstracts:

: Plenary session 1: Opening and keynote lectures
Ann Oncol 16: iii15; doi:10.1093/annonc/mdi601 [PDF]

: Plenary session 2: Growth factor receptor and cell signaling inhibitors
Ann Oncol 16: iii16; doi:10.1093/annonc/mdi602 [PDF]

: Plenary session 3: Emerging drug options for renal cell cancer
Ann Oncol 16: iii17-iii20; doi:10.1093/annonc/mdi603 [PDF]

: Plenary session 4: Proffered papers
Ann Oncol 16: iii21-iii22; doi:10.1093/annonc/mdi604 [PDF]

: Plenary session 5: Apoptosis as a drug target
Ann Oncol 16: iii23-iii24; doi:10.1093/annonc/mdi605 [PDF]

: Plenary session 6: Immunotherapy of cancer
Ann Oncol 16: iii25; doi:10.1093/annonc/mdi606 [PDF]

: Plenary session 7: Regulatory, strategic and methodological issues in the development of targeted anticancer agents
Ann Oncol 16: iii26; doi:10.1093/annonc/mdi607 [PDF]

: Plenary session 8: Anti-angiogenic and anti-vascular agents
Ann Oncol 16: iii27-iii28; doi:10.1093/annonc/mdi608 [PDF]

: Plenary session 9: Other targeted therapies
Ann Oncol 16: iii29-iii30; doi:10.1093/annonc/mdi609 [PDF]

: Poster session 1: Drug design and screening
Ann Oncol 16: iii31-iii34; doi:10.1093/annonc/mdi610 [PDF]

: Poster session 2: New drug targets
Ann Oncol 16: iii35-iii36; doi:10.1093/annonc/mdi611 [PDF]

: Poster session 3: Targeted drug delivery
Ann Oncol 16: iii37; doi:10.1093/annonc/mdi612 [PDF]

: Poster session 4: Molecular diagnosis, patient selection and prognosis
Ann Oncol 16: iii38-iii39; doi:10.1093/annonc/mdi613 [PDF]

: Poster session 5: Erb receptors and signalling
Ann Oncol 16: iii40-iii42; doi:10.1093/annonc/mdi614 [PDF]

: Poster session 6: Signal transduction modulators
Ann Oncol 16: iii43-iii44; doi:10.1093/annonc/mdi615 [PDF]

: Poster session 7: Angiogenesis
Ann Oncol 16: iii45-iii46; doi:10.1093/annonc/mdi616 [PDF]

: Poster session 8: Immunotherapeutic approaches
Ann Oncol 16: iii47-iii48; doi:10.1093/annonc/mdi617 [PDF]

: Poster session 9: Other agents
Ann Oncol 16: iii49; doi:10.1093/annonc/mdi618 [PDF]

Subject index:

: Subject index
Ann Oncol 16: iii51-iii52; doi:10.1093/annonc/mdi619 [PDF]

Author index:

: Author index
Ann Oncol 16: iii53-iii55; doi:10.1093/annonc/mdi620 [PDF]

Annals of Oncology

Introduction:

Abstracts:

Subject index:

Author index: